Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Akebia Therapeutics Inc. buy HC Wainwright

Akebia Therapeutics Inc.
Start price
€0.92
17.11.23 / 50%
Target price
€4.60
17.11.24
Performance (%)
81.13%
End price
€1.66
18.11.24
Summary
This prediction ended on 18.11.24 with a price of €1.66. With a performance of 81.13% the BUY prediction by HC_Wainwright was a big success. HC_Wainwright has a follow-up prediction for Akebia Therapeutics Inc. where he still thinks Akebia Therapeutics Inc. is a Buy. HC_Wainwright has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Akebia Therapeutics Inc. -4.226% -4.226% -21.491%
iShares Core DAX® -0.793% 4.201% 19.951%
iShares Nasdaq 100 -2.376% 0.857% 4.704%
iShares Nikkei 225® -2.701% -0.147% 12.609%
iShares S&P 500 -1.689% 1.244% 3.144%

Comments by HC_Wainwright for this prediction

In the thread Akebia Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 81.13%
Target price 4.598
Change
Ends at 17.11.24

Akebia Therapeutics, Inc. (NASDAQ: AKBA) had its price target raised by analysts at HC Wainwright from $3.75 to $5.00. They now have a "buy" rating on the stock.
Ratings data for AKBA provided by MarketBeat

HC Wainwright 
0
Report Share
17.11.23
In the thread Trading Akebia Therapeutics Inc.
Prediction Buy
Perf. (%) 81.13%
Target price 4.598
Change
Ends at 17.11.24

Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten

HC Wainwright 
0
Report Share
18.11.24

Current prediction by HC_Wainwright for Akebia Therapeutics Inc.

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.82
14.01.25
€7.29
14.01.26
-26.58%
18.12.25

HC Wainwright 
14.01.25 50%

Stopped prediction by HC_Wainwright for Akebia Therapeutics Inc.

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.27
02.12.25
€5.17
02.12.26
12.70%
18.12.25

HC Wainwright 
02.12.25 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.12
04.06.25
€7.03
04.06.26
-54.20%
18.12.25

HC Wainwright 
04.06.25 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.61
04.04.25
€6.78
04.04.26
-11.41%
18.12.25

HC Wainwright 
04.04.25 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.92
14.03.25
€6.91
14.03.26
-25.46%
18.12.25

HC Wainwright 
14.03.25 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.30
23.01.25
€7.19
23.01.26
-37.87%
18.12.25

HC Wainwright 
23.01.25 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.53
23.10.24
€6.96
23.10.25
63.81%
24.10.25

HC Wainwright 
23.10.24 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.19
08.10.24
€6.83
08.10.25
101.51%
09.10.25

HC Wainwright 
08.10.24 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.26
06.09.24
€6.74
06.09.25
95.40%
07.09.25

HC Wainwright 
06.09.24 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.82
28.03.24
€5.55
28.03.25
-5.70%
29.03.25

HC Wainwright 
28.03.24 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.11
27.09.23
€3.55
27.09.24
2.70%
28.09.24

HC Wainwright 
27.09.23 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.27
28.08.23
€3.47
28.08.24
9.45%
29.08.24

HC Wainwright 
28.08.23 50%